Prilenia Therapeutics is a clinical stage biotech company developing its lead drug candidate, pridopidine, for Huntington’s Disease and ALS. It was founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.
Location: Israel, Tel Aviv District, Herzliya
Total raised: $105.5M
Investors 2
| Date | Name | Website |
| - | Forbion | forbion.co... |
| 23.02.2021 | ALS Invest... | alsinvestm... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.12.2021 | Series B | $43M | - |
| 03.06.2020 | Series A | $62.5M | ALS Invest... |
Mentions in press and media 12
| Date | Title | Description | Source |
| 12.04.2024 | Prilenia to Present Latest Research from its Pridopidine Pro... | NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical s... | forbion.co... |
| 03.04.2024 | Prilenia Names Jina Swartz, M.D. Ph.D., as Chief Medical Off... | NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical s... | forbion.co... |
| 12.03.2024 | Prilenia Plans to Submit Marketing Authorization Application... | NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)-- Prilenia Therapeutics B.V., a clinical ... | forbion.co... |
| 12.03.2024 | Prilenia Plans to Submit Marketing Authorization Application... | -Following positive pre-submission meetings with regulators, Prilenia plans to submit its MAA for pr... | svhealthin... |
| 28.03.2023 | Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-H... | PROOF-HD is the only late-stage study in Huntington’s disease targeting clinical progression; toplin... | svhealthin... |
| 23.02.2023 | Prilenia Announces Topline Results for Pridopidine in Phase ... | Naarden, NL and WALTHAM, Mass, 23 February 2023 – Prilenia Therapeutics B.V., a clinical stage biote... | svhealthin... |
| 03.12.2021 | Prilenia Closes Oversubscribed $43 Million in Series B Finan... | Naarden, NL, 3 November 2021 – Prilenia Therapeutics B.V., a clinical stage biotech company focused ... | forbion.co... |
| 05.11.2021 | Prilenia picks up $43M Series B | Clinical-stage biotech startup Prilenia Therapeutics has raised a $43 million round led by Sands Cap... | pitchbook.... |
| 04.11.2021 | Dutch-Israeli startup Prilenia Therapeutics raises €37.22M t... | Prilenia Therapeutics, a clinical-stage biotech company that develops novel treatments for neurodege... | siliconcan... |
| 03.11.2021 | Prilenia Closes Oversubscribed $43 Million in Series B Finan... | Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments ... | marketscre... |
Show more